Peptilogics hauls in $5.5 mln Series A

Pittsburgh and Silicon Valley-based Peptilogics, a provider of a peptide platform that treats multidrug-resistant bacterial infections, has secured $5.5 million in Series A financing. The investors included Peter Thiel, Stefan Roever and BlueTree Ventures. In addition to the funding, Peptilogics has named Sanjay Kakkar as CEO.

North AmericaUSBriefs